Comparative immunological studies on Corynebacterium parvum polysaccharide and Fusobacterium varium lipopolysaccharide
Marx, A.; Sălăgeanu, A.; Olinescu, A.; Gancevici, G.
Archives Roumaines de Pathologie Experimentales et de Microbiologie 46(1): 57-65
1987
ISSN/ISBN: 0004-0037 PMID: 3435242 Document Number: 301748
Document emailed within 1 workday
Related Documents
Tomecki, J.; Mara, M. 1987: The immunological activities of components isolated from Corynebacterium parvum in mice injected with polyoma tumor cells Neoplasma 34(1): 15-22Chen, M.F.; Suzuki, H.; Yano, S. 1992: Induction of murine lymphokine-activated killer-like cells by Corynebacterium parvum (C. parvum) in vitro: lysis of tumor cells and macrophages by C. parvum-induced killer cells Anticancer Research 12(2): 451-456
Budzyński, W. 1982: Studies on antitumor effect of corynebacterium parvum and pustulan on Lewis lung carcinoma in mice Archivum Immunologiae et Therapiae Experimentalis 30(5-6): 379-384
Medenica, R.; Girard, J.P.; Maurice, P. 1977: Clinical trial with Corynebacterium parvum Developments in Biological Standardization 38: 483-485
Suponits'ka, V.M.; Barshtein, I.A.; Smolii, L.S. 1975: Immunological and morphological studies of the polysaccharide zymosan effect on the course of allergic reaction Mikrobiolohichnyi Zhurnal 37(5): 610-615
Zola, H. 1975: Mitogenicity of Corynebacterium parvum for mouse lymphocytes Clinical and Experimental Immunology 22(3): 514-521
Brisset, J.M.; Veillon, B.; Carmona, C. 1977: The local effect of intravesical Corynebacterium parvum in the dog. a preliminary study Developments in Biological Standardization 38: 379-380
Gatenby, P.A.; Basten, A.; Tattersall, M.H.; Fox, R.M. 1980: Autoantibodies in cancer patients given Corynebacterium parvum/levamisole immunotherapy Lancet 1(8177): 1082
Douple, E.B. 1977: Treatment of an intracerebral rat brain tumor with Corynebacterium parvum and radiation National Cancer Institute Monograph 46: 179-184
Karakousis, C.P.; Didolkar, M.S.; Han, T. 1981: Chemoimmunotherapy (DTIC and Corynebacterium parvum) for disseminated malignant melanoma Cancer Treatment Reports 65(9-10): 925-926
Warr, G.W.; Sljivić, V.S. 1974: Enhancement and depression of the antibody response in mice caused by Corynebacterium parvum Clinical and Experimental Immunology 17(3): 519-532
Kirchner, H.; Chmielarczyk, W.; Storch, E.; Schindler, L. 1984: Antiviral effects of Corynebacterium parvum and its effect on the interferon system in mice Behring Institute Mitteilungen 74: 183-188
Karakousis, C.P.; Didolkar, M.S.; Lopez, R.; Baffi, R.; Moore, R.; Holyoke, E.D. 1979: Chemoimmunotherapy (DTIC and Corynebacterium parvum) as adjuvant treatment in malignant melanoma Cancer Treatment Reports 63(11-12): 1739-1743
Watson, S.R.; Sljivić, V.S. 1976: The role of macrophages in the adjuvant effect on antibody production of Corynebacterium parvum Clinical and Experimental Immunology 23(1): 149-153
Foresti, V.; Scolari, N.; Villa, A.; Parisio, E. 1989: Anatomical study of the fibrosing action of Corynebacterium parvum in malignant pleural effusion Minerva Medica 80(10): 1069-1072
Fisher, B.; Gebhardt, M.C.; Saffer, E.A.; Fisher, E.R. 1979: Effect of Corynebacterium parvum in prevention and reversal of atrophy of the liver following portacaval shunt Surgery Gynecology and Obstetrics 149(2): 168-172
Kiya, K.; Toge, T.; Harada, K.; Uozumi, T.; Hattori, T. 1981: Effect of intracerebral administration of Corynebacterium parvum on the growth of brain tumors in mice Gan 72(3): 446-450
Barth, R.F.; Singla, O. 1977: Distribution of technetium-99m labeled Corynebacterium parvum in normal and tumor bearing mice Developments in Biological Standardization 38: 129-135
Howard, J.G.; Christie, G.H.; Jacob, M.J.; Elson, J. 1970: Studies on immunological paralysis. 3. Recirculation and antibody-neutralizing activity of 14C-labelled type 3 pneumococcal polysaccharide in paralysed mice Clinical and Experimental Immunology 7(4): 583-596
Soyka, L.F.; Hunt, W.G.; Knight, S.E.; Foster, R.S. 1976: Decreased liver and lung drug-metabolizing activity in mice treated with Corynebacterium parvum Cancer Research 36(12): 4425-4428